Ho Eric C M, Lam Karen S L, Chen Yuk Shan, Yip Johnny C W, Arvindakshan Meena, Yamagishi Shin-Ichiro, Yagihashi Soroku, Oates Peter J, Ellery Craig A, Chung Stephen S M, Chung Sookja K
Department of Anatomy, The University of Hong Kong, Hong Kong, SAR, China.
Diabetes. 2006 Jul;55(7):1946-53. doi: 10.2337/db05-1497.
The exaggerated flux through polyol pathway during diabetes is thought to be a major cause of lesions in the peripheral nerves. Here, we used aldose reductase (AR)-deficient (AR(-/-)) and AR inhibitor (ARI)-treated mice to further understand the in vivo role of polyol pathway in the pathogenesis of diabetic neuropathy. Under normal conditions, there were no obvious differences in the innervation patterns between wild-type AR (AR(+/+)) and AR(-/-) mice. Under short-term diabetic conditions, AR(-/-) mice were protected from the reduction of motor and sensory nerve conduction velocities observed in diabetic AR(+/+) mice. Sorbitol levels in the sciatic nerves of diabetic AR(+/+) mice were increased significantly, whereas sorbitol levels in the diabetic AR(-/-) mice were significantly lower than those in diabetic AR(+/+) mice. In addition, signs of oxidative stress, such as increased activation of c-Jun NH(2)-terminal kinase (JNK), depletion of reduced glutathione, increase of superoxide formation, and DNA damage, observed in the sciatic nerves of diabetic AR(+/+) mice were not observed in the diabetic AR(-/-) mice, indicating that the diabetic AR(-/-) mice were protected from oxidative stress in the sciatic nerve. The diabetic AR(-/-) mice also excreted less 8-hydroxy-2'-deoxyguanosine in urine than diabetic AR(+/+) mice. The structural abnormalities observed in the sural nerve of diabetic AR(+/+) mice were less severe in the diabetic AR(-/-) mice, although it was only mildly protected by AR deficiency under short-term diabetic conditions. Signs of oxidative stress and functional and structural abnormalities were also inhibited by the ARI fidarestat in diabetic AR(+/+) nerves, similar to those in diabetic AR(-/-) mice. Taken together, increased polyol pathway flux through AR is a major contributing factor in the early signs of diabetic neuropathy, possibly through depletion of glutathione, increased superoxide accumulation, increased JNK activation, and DNA damage.
糖尿病期间通过多元醇途径的通量增加被认为是外周神经病变的主要原因。在此,我们使用醛糖还原酶(AR)缺陷(AR(-/-))和AR抑制剂(ARI)处理的小鼠,以进一步了解多元醇途径在糖尿病性神经病变发病机制中的体内作用。在正常条件下,野生型AR(AR(+/+))和AR(-/-)小鼠的神经支配模式没有明显差异。在短期糖尿病条件下,AR(-/-)小鼠免受糖尿病AR(+/+)小鼠中观察到的运动和感觉神经传导速度降低的影响。糖尿病AR(+/+)小鼠坐骨神经中的山梨醇水平显著升高,而糖尿病AR(-/-)小鼠中的山梨醇水平明显低于糖尿病AR(+/+)小鼠。此外,在糖尿病AR(+/+)小鼠坐骨神经中观察到的氧化应激迹象,如c-Jun氨基末端激酶(JNK)激活增加、还原型谷胱甘肽耗竭、超氧化物形成增加和DNA损伤,在糖尿病AR(-/-)小鼠中未观察到,这表明糖尿病AR(-/-)小鼠免受坐骨神经氧化应激的影响。糖尿病AR(-/-)小鼠尿中8-羟基-2'-脱氧鸟苷的排泄量也比糖尿病AR(+/+)小鼠少。糖尿病AR(+/+)小鼠腓肠神经中观察到的结构异常在糖尿病AR(-/-)小鼠中较轻,尽管在短期糖尿病条件下仅受到AR缺陷的轻微保护。氧化应激迹象以及功能和结构异常在糖尿病AR(+/+)神经中也被ARI非达司他抑制,类似于糖尿病AR(-/-)小鼠。综上所述,通过AR增加的多元醇途径通量是糖尿病性神经病变早期迹象的主要促成因素,可能是通过谷胱甘肽耗竭、超氧化物积累增加、JNK激活增加和DNA损伤。